Veeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025.
- Revenue
- +17.6%
- EPS
- +36.6%
- Free cash flow
- −0.62%
Quarter to July 2026, against a year earlier
Follow VEEV
Alert me
Veeva Systems Inc. (VEEV) Total debt
Veeva Systems Inc.'s total debt at the end of fiscal 2023 was $61.0M, up 10.9% from $55.0M in fiscal 2022. At the end of the quarter to 31 October 2023 it was $58.0M. Veeva Systems Inc. ranks 18th of 42 Health Information Services companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2023 | $61.0M | 10.91% |
| FY2022 | $55.0M | (12.70%) |
| FY2021 | $63.0M | 14.55% |
| FY2020 | $55.0M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Oct 2023 | $58.0M | (1.69%) |
| Jul 2023 | $59.0M | 1.72% |
| Apr 2023 | $58.0M | (4.92%) |
| Jan 2023 | $61.0M | (1.61%) |
| 15 more quarters | Free account |
Total debt against peers
| Company | Total debt |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | $2.2B |
| WAY Waystar Holding Corp. compare | $1.5B |
| TEM Tempus AI, Inc. compare | $1.4B |
| HQY HealthEquity, Inc. compare | $931.1M |
| HTFL Heartflow, Inc. compare | $182.4M |
| VEEV Veeva Systems Inc. | $58.0M |
| DOCS Doximity, Inc. compare | $15.0M |
| PRVA Privia Health Group, Inc. compare | $5.8M |
| HNGE Hinge Health Inc. compare | — |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on VEEV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement